Household & Personal Products

First‑quarter earnings reveal Coty’s steady fragrance sales and optimistic second‑half growth, with net income of $67.9 m and a $1.58 bn revenue outlook.

Olaplex Q3 2025: $114.6 M sales, modest EPS beat, specialty retail decline, DTC drop, professional channel steadies, analysts expect cautious recovery.

Explore RONN’s unique blend of consumer personal care and professional dental products—discover its market strategy, volatility, and growth prospects.

Investor alert: Coty Inc. faces fraud claims. Learn how the investigation may impact shareholder value, market price, and the company’s future.

Henkel’s latest treasury‑share purchase signals confidence in its intrinsic value, offering investors a fresh look at potential gains and capital‑market transparency.

Discover why Qingdao Kingking Applied Chemistry remains a steady, diversified growth choice amid volatile China‑Korea free‑trade swings.

Church & Dwight Q3 beats estimates, lifts 2025 outlook, with stronger detergent sales, lower tariffs, and solid cash flow driving a fresh growth push.

Colgate‑Palmolive’s Q3 2025 earnings show steady 2% revenue growth and EPS beating estimates, but a trimmed sales outlook amid consumer restraint.

Church & Dwight’s Q3 earnings outlook shows a strong rebound—positive EPS, steady dividends, and growth in contraceptives—positioning the $20 B stock for upside.

L’Oréal is experiencing a digital surge, driven by its e-commerce strategy and shifting luxury consumer behavior, which is expected to reinforce its market leadership and potentially justify a higher valuation.